Menu
Back to User profile » Dr Ira Jacobs
Papers published by Dr Ira Jacobs:
Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews
Lee LJ, Kwon CS, Forsythe A, Mamolo CM, Masters ET, Jacobs IA
ClinicoEconomics and Outcomes Research 2020, 12:693-709
Published Date: 23 November 2020
Drug tendering: drug supply and shortage implications for the uptake of biosimilars
Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG
ClinicoEconomics and Outcomes Research 2017, 9:573-584
Published Date: 29 September 2017
Can biosimilars help achieve the goals of US health care reform?
Boccia R, Jacobs I, Popovian R, de Lima Lopes Jr G
Cancer Management and Research 2017, 9:197-205
Published Date: 1 June 2017
Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape
Subramanian J, Cavenagh J, Desai B, Jacobs I
Cancer Management and Research 2017, 9:131-140
Published Date: 24 April 2017
A practical guide about biosimilar data for health care providers treating inflammatory diseases
Markenson J, Alvarez DF, Jacobs I, Kirchhoff C
Biologics: Targets and Therapy 2017, 11:13-21
Published Date: 24 February 2017
Biosimilars and the extrapolation of indications for inflammatory conditions
Tesser JRP, Furst DE, Jacobs I
Biologics: Targets and Therapy 2017, 11:5-11
Published Date: 17 February 2017
Patient attitudes and understanding about biosimilars: an international cross-sectional survey
Jacobs I, Singh E, Sewell KL, AL-Sabbagh A, Shane LG
Patient Preference and Adherence 2016, 10:937-948
Published Date: 26 May 2016
Development of biosimilars in an era of oncologic drug shortages
Li E, Subramanian J, Anderson S, Thomas D, McKinley J, Jacobs IA
Drug Design, Development and Therapy 2015, 9:3247-3255
Published Date: 24 June 2015